OGEN (Oragenics) Shiller PE Ratio: (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OGEN Oragenics Inc OGEN
30 GF Score
Price $0.52
! 2 Warning Signs
View Full Analysis

What is Oragenics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Oragenics  (AMEX:OGEN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Oragenics Shiller PE Ratio Related Terms


Oragenics Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Oragenics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oragenics Shiller PE Ratio Chart

Oragenics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oragenics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OGEN vs CMND, SLXN, GRI: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Oragenics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oragenics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oragenics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Oragenics's Shiller PE Ratio falls into.


OGEN
30GF Score
Oragenics Inc OGEN
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oragenics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Oragenics's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Oragenics's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.57/333.9520*333.9520
=-0.570

Current CPI (Jun. 2026) = 333.9520.

Oragenics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -720.000 241.428 -995.930
201612 -1,026.000 241.432 -1,419.177
201703 -720.000 243.801 -986.236
201706 -450.000 244.955 -613.494
201709 -756.000 246.819 -1,022.886
201712 -540.000 246.524 -731.507
201803 -756.000 249.554 -1,011.676
201806 -684.000 251.989 -906.481
201809 -630.000 252.439 -833.428
201812 -168.529 251.233 -224.018
201903 -198.000 254.202 -260.118
201906 -180.000 256.143 -234.679
201909 -144.000 256.759 -187.293
201912 -144.000 256.974 -187.136
202003 -198.000 258.115 -256.175
202006 -432.000 257.797 -559.616
202009 -144.000 260.280 -184.759
202012 -90.000 260.474 -115.388
202103 -90.000 264.877 -113.470
202106 -54.000 271.696 -66.373
202109 -72.000 274.310 -87.655
202112 -26.699 278.802 -31.980
202203 -68.700 287.504 -79.799
202206 -55.500 296.311 -62.550
202209 -59.700 296.808 -67.171
202212 -27.000 296.797 -30.380
202303 -42.300 301.836 -46.801
202306 -45.300 305.109 -49.582
202309 -25.500 307.789 -27.668
202312 -164.400 306.746 -178.981
202403 -21.000 312.332 -22.454
202406 -15.270 314.175 -16.231
202409 -11.320 315.301 -11.990
202412 -7.993 315.605 -8.458
202503 -3.650 319.799 -3.812
202506 -3.100 322.561 -3.209
202509 -1.960 324.800 -2.015
202512 -0.535 324.054 -0.551
202603 -0.510 330.213 -0.516
202606 -0.570 333.952 -0.570

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oragenics Business Description

Address 9015 Town Center Parkway, Suite 143, Lakewood Ranch, FL, USA, 34202
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
30GF Score

Get the complete analysis for OGEN

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price